Study #2024-0071
Enfortumab Vedotin with radiation for locally Advanced Bladder Cancer (CONSOLIDATE)
MD Anderson Study Status
Enrolling
Treatment Agent
Enfortumab Vedotin
Description
To learn if the combination of enfortumab vedotin plus radiation therapy could help to control the disease.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Advanced Bladder Cancer
Study phase:
Physician name:
Comron Hassanzadeh
Department:
Radiation Oncology
For general questions about clinical trials:
1-855-982-0789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.